Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation
about
ROS and brain diseases: the good, the bad, and the uglyA longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophreniaNeurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)Theranostic Biomarkers for SchizophreniaMeasurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment.Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.Effect of Boric Acid Supplementation on the Expression of BDNF in African Ostrich Chick Brain.BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis.Clozapine for the treatment of schizophrenia.Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.Neurogenic locus notch homolog protein 4 and brain-derived neurotrophic factor variants combined effect on schizophrenia susceptibility.BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness.
P2860
Q27014070-B5FB1752-633A-4326-A624-3E6ACC77A5BCQ28539784-6FF1A07F-AF89-46BB-AE82-FF27596AE605Q30897232-34F6397D-CC9F-45E5-A18C-2014C289FE42Q33624412-CE0BCB12-F430-4E0D-86DE-06B201737069Q35094654-F391CC38-5E7B-4640-BADB-71E8F5DF0855Q35550864-78B2BEE2-8CF8-4252-9EEF-6367CEC9EF46Q35727375-CEFCE490-F896-41A2-9962-8EBCE7094F06Q36377832-BCDA348E-3351-4AE0-A276-8B90DCBB1878Q37615022-02BC9CC9-AC65-4E91-9C7D-4B7887B0C100Q38026886-346CD020-1B6C-435A-A4B8-9C7C6AB7AFAFQ38209971-A526FCEB-7D41-4280-88D8-316AE739D143Q38635337-53E101D5-DC3B-4098-9632-CBC6045D5476Q48215288-3FE3DD14-63A4-4D06-9FDA-5AF948ADE586Q48494934-90C01D76-5A83-4069-8B80-373FD21E7B45Q48593832-0A84C276-94C7-49C7-899D-5FCA9D864A10
P2860
Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 21 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@en
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@nl
type
label
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@en
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@nl
prefLabel
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@en
Serum brain-derived neurotroph ...... hrenia: A positive correlation
@nl
P2093
P50
P1433
P1476
Serum brain-derived neurotroph ...... hrenia: a positive correlation
@en
P2093
Camila Lersch
Clarissa Severino Gama
Flavio Kapczinski
Inês Chendo
Mariana Pedrini
Márcia Kauer-Sant'anna
Paulo Silva Belmonte-de-Abreu
P304
P356
10.1016/J.NEULET.2011.01.039
P407
P577
2011-01-21T00:00:00Z